Related Experiment Video

Updated: Jun 23, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia

Heike von Baum1, Tobias Welte, Reinhard Marre

  • 1Institute for Medical Microbiology and Hygiene, Ulm University Hospital, Ulm, Germany. heike.von-baum@uniklinik-ulm.de

BMC Infectious Diseases
|May 15, 2009
PubMed
Abstract

Insights

Mycoplasma pneumoniae pneumonia (MPP) is common in mild to moderate community-acquired pneumonia (CAP) and typically presents with milder symptoms and better outcomes. Current guidelines for atypical pathogen coverage in CAP may need reconsideration due to the largely benign course of MPP.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Current guidelines recommend broad empiric antimicrobial treatment for community-acquired pneumonia (CAP), including atypical pathogens.
  • The specific impact of individual atypical pathogens, such as Mycoplasma pneumoniae, warrants further investigation.

Purpose of the Study:

  • To investigate the incidence, clinical characteristics, and outcomes of Mycoplasma pneumoniae pneumonia (MPP) in patients with CAP.
  • To evaluate the clinical significance of MPP in the context of current CAP treatment recommendations.

Main Methods:

  • Analysis of prospective data from 4532 CAP patients in the German CAPNETZ cohort.
  • Diagnosis of MPP confirmed by positive PCR and/or positive IgM titer in acute serum samples.

Main Results:

  • MPP was diagnosed in 6.8% of patients (307 cases).
  • MPP patients were significantly younger, had fewer comorbidities, and presented with less severe disease compared to other etiologies.
  • MPP was associated with lower inflammatory markers, shorter hospitalization, reduced need for mechanical ventilation, and minimal mortality.

Conclusions:

  • Mycoplasma pneumoniae pneumonia (MPP) is a common condition with a distinct clinical presentation and a generally favorable prognosis.
  • The findings suggest that current recommendations for routine atypical pathogen coverage in mild to moderate CAP may need re-evaluation, particularly in regions with similar epidemiological profiles to Germany.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.